MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

Search

Phibro Animal Health Corp

Closed

SectorHealthcare

17.94 4.24

Overview

Share price change

24h

Current

Min

16.91

Max

18

Key metrics

By Trading Economics

Income

-3.8M

3.2M

Sales

49M

309M

P/E

Sector Avg

34.438

57.333

EPS

0.54

Dividend yield

2.78

Profit margin

1.03

Employees

1,940

EBITDA

-4.9M

26M

Recommendations

By TipRanks

Recommendations

Sell

12 Months Forecast

+23.55% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

2.78%

2.63%

Next Earnings

7 May 2025

Next Dividend date

25 Jun 2025

Market Stats

By TradingEconomics

Market Cap

670M

Previous open

13.7

Previous close

17.94

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

Phibro Animal Health Corp Chart

Past performance is not a reliable indicator of future results.

Related News

29 Apr 2024, 10:57 UTC

Acquisitions, Mergers, Takeovers

Zoetis to Sell Medicated-Feed-Additive Portfolio to Phibro for $350 Million

Peer Comparison

Price change

Phibro Animal Health Corp Forecast

Price Target

By TipRanks

23.55% upside

12 Months Forecast

Average 21.25 USD  23.55%

High 25 USD

Low 18 USD

Based on 4 Wall Street analysts offering 12 month price targets forPhibro Animal Health Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Sell

4 ratings

0

Buy

2

Hold

2

Sell

Technical Score

By Trading Central

14.2 / 15.6Support & Resistance

Short Term

Weak Bullish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Strong Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Phibro Animal Health Corp

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.